- Home
- / Hemab Therapeutics
Hemab Therapeutics
Hemab Therapeutics Summary
Company Summary
- Overview
- Hemab Therapeutics Holdings is a clinical-stage biotechnology company. It develops therapies for blood coagulation disorders.
- Type
- Public
- Status
- Active
- Founded
- 2026
- HQ
- Cambridge, MA, US | view all locations
- Website
- https://www.hemab.com
- Cybersecurity rating
- Sectors
Table of Contents
Key People
LocationsView all
1 location detected
Cambridge, MA HQ
United States
101 Main Street, Suite 1220
Hemab Therapeutics Financials
Summary Financials
- Net income (Q1, 2026)
- ($22.7M)
- Cash (Q1, 2026)
- $49.9M
- EBIT (Q1, 2026)
- ($23.6M)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026